Doxorubicin induces bone marrow B-cell dysmaturation via Ebf1/Pax5 suppression to drive peripheral B-cell reduction in cardiotoxicity
20 June 2026 (15:00 - 15:15)
Organised by: 
About the speaker
Shanghai The Central Hospital of Songjiang District, Shanghai (China)
1 More presentation in this session
Doctor J. Brauer (Heidelberg, DE)
Access the full session
The Event
ESC Cardio-Oncology 2026
20 June 2026
15:00 CET
You may be interested in
Congress Session
Congress Session
